Genome-Wide Gene-Environment Study Identifies Glutamate Receptor Gene GRIN2A as a Parkinson's Disease Modifier Gene via Interaction with Coffee
2011

Coffee and Genetics: A Study on Parkinson's Disease

Sample size: 2389 publication 10 minutes Evidence: high

Author Information

Author(s): Hamza Taye H., Chen Honglei, Hill-Burns Erin M., Rhodes Shannon L., Montimurro Jennifer, Kay Denise M., Tenesa Albert, Kusel Victoria I., Sheehan Patricia, Eaaswarkhanth Muthukrishnan, Yearout Dora, Samii Ali, Roberts John W., Agarwal Pinky, Bordelon Yvette, Park Yikyung, Wang Liyong, Gao Jianjun, Vance Jeffery M., Kendler Kenneth S., Bacanu Silviu-Alin, Scott William K., Ritz Beate, Nutt John, Factor Stewart A., Zabetian Cyrus P., Payami Haydeh

Primary Institution: New York State Department of Health Wadsworth Center

Hypothesis

Does the glutamate receptor gene GRIN2A interact with coffee consumption to modify the risk of developing Parkinson's disease?

Conclusion

The study found that variations in the GRIN2A gene significantly influence the protective effect of coffee against Parkinson's disease, particularly in heavy coffee drinkers.

Supporting Evidence

  • The study identified GRIN2A as a significant gene associated with Parkinson's disease risk in heavy coffee drinkers.
  • Heavy coffee drinkers with the GRIN2A_T allele had a 59% lower risk of developing Parkinson's disease compared to those with the GRIN2A_CC genotype.
  • The findings suggest that gene-environment interactions are crucial for understanding the genetic basis of Parkinson's disease.

Takeaway

Drinking coffee might help some people avoid Parkinson's disease, especially if they have a specific gene called GRIN2A.

Methodology

The study used genome-wide genotype data and coffee consumption data from 1,458 people with Parkinson's disease and 931 without, performing genome-wide association and interaction studies.

Potential Biases

Potential confounding factors such as smoking and other dietary habits were considered, but residual confounding cannot be ruled out.

Limitations

The study primarily focused on non-Hispanic Caucasian individuals, which may limit the generalizability of the findings to other populations.

Participant Demographics

Participants included 1,458 individuals with Parkinson's disease and 931 controls, primarily non-Hispanic Caucasian.

Statistical Information

P-Value

6×10−7

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pgen.1002237

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication